These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14567545)

  • 1. Discovery and evaluation of terephthalic acid derivatives as potent alpha4beta1 integrin antagonists.
    Müller G; Albers M; Hessler G; Lehmann TE; Okigami H; Tajimi M; Bacon K; Rölle T
    J Enzyme Inhib Med Chem; 2003 Aug; 18(4):309-12. PubMed ID: 14567545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and evaluation of piperidinyl carboxylic acid derivatives as potent alpha(4)beta(1) integrin antagonists.
    Müller G; Albers M; Fischer R; Hessler G; Lehmann TE; Okigami H; Tajimi M; Bacon K; Rölle T
    Bioorg Med Chem Lett; 2001 Dec; 11(23):3019-21. PubMed ID: 11714601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4.
    Okigami H; Takeshita K; Tajimi M; Komura H; Albers M; Lehmann TE; Rölle T; Bacon KB
    Eur J Pharmacol; 2007 Mar; 559(2-3):202-9. PubMed ID: 17234179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-(3-phenylsulfonyl-3-piperidinoyl)-phenylalanine derivatives as potent, selective VLA-4 antagonists.
    Gutteridge CE; de Laszlo SE; Kamenecka TM; McCauley E; van Riper G; Mumford RA; Kidambi U; Egger LA; Tong S; Hagmann WK
    Bioorg Med Chem Lett; 2003 Mar; 13(5):885-90. PubMed ID: 12617914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of VLA-4/CS-1 and VLA-4/VCAM adhesion inhibition.
    Mehlin C
    Curr Protoc Pharmacol; 2004 May; Chapter 12():Unit 12.7. PubMed ID: 22294119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amidines as amide bond replacements in VLA-4 antagonists.
    Kamenecka TM; Park YJ; Lin LS; de Laszlo S; McCauley ED; Van Riper G; Egger L; Kidambi U; Mumford RA; Tong S; Tang W; Colletti A; Teffera Y; Stearns R; MacCoss M; Schmidt JA; Hagmann WK
    Bioorg Med Chem Lett; 2004 May; 14(9):2323-6. PubMed ID: 15081033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into phenylalanine derivatives recognition of VLA-4 integrin: from a pharmacophoric study to 3D-QSAR and molecular docking analyses.
    Macchiarulo A; Costantino G; Meniconi M; Pleban K; Ecker G; Bellocchi D; Pellicciari R
    J Chem Inf Comput Sci; 2004; 44(5):1829-39. PubMed ID: 15446843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight heparin inhibits sickle erythrocyte adhesion to VCAM-1 through VLA-4 blockade in a standardized microfluidic flow adhesion assay.
    Lancelot M; White J; Sarnaik S; Hines P
    Br J Haematol; 2017 Aug; 178(3):479-481. PubMed ID: 27341635
    [No Abstract]   [Full Text] [Related]  

  • 9. N-Cycloalkanoyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists.
    Sidduri A; Tilley JW; Hull K; Lou JP; Kaplan G; Sheffron A; Chen L; Campbell R; Guthrie R; Huang TN; Huby N; Rowan K; Schwinge V; Renzetti LM
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2475-8. PubMed ID: 12161161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-Aroyl-L-phenylalanine derivatives as VCAM/VLA-4 antagonists.
    Sidduri A; Tilley JW; Lou JP; Chen L; Kaplan G; Mennona F; Campbell R; Guthrie R; Huang TN; Rowan K; Schwinge V; Renzetti LM
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2479-82. PubMed ID: 12161162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Focused library approach for identification of new N-acylphenylalanines as VCAM/VLA-4 antagonists.
    Chen L; Trilles R; Miklowski D; Huang TN; Fry D; Campbell R; Rowan K; Schwinge V; Tilley JW
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1679-82. PubMed ID: 12039589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the very late adhesion molecule 4 antagonist WAY103 on human peripheral blood eosinophil vascular cell adhesion molecule 1-dependent functions.
    Sedgwick JB; Jansen KJ; Kennedy JD; Kita H; Busse WW
    J Allergy Clin Immunol; 2005 Oct; 116(4):812-9. PubMed ID: 16210055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,3-Diphenylpropionic acids as potent VLA-4 antagonists.
    Hoshina Y; Ikegami S; Okuyama A; Fukui H; Inoguchi K; Maruyama T; Fujimoto K; Matsumura Y; Aoyama A; Harada T; Tanaka H; Nakamura T
    Bioorg Med Chem Lett; 2005 Jan; 15(1):217-20. PubMed ID: 15582442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation.
    Garmy-Susini B; Jin H; Zhu Y; Sung RJ; Hwang R; Varner J
    J Clin Invest; 2005 Jun; 115(6):1542-51. PubMed ID: 15902308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting roles for domain 4 of VCAM-1 in the regulation of cell adhesion and soluble VCAM-1 binding to integrin alpha4beta1.
    Woodside DG; Kram RM; Mitchell JS; Belsom T; Billard MJ; McIntyre BW; Vanderslice P
    J Immunol; 2006 Apr; 176(8):5041-9. PubMed ID: 16585601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VLA-4 blockade by natalizumab inhibits sickle reticulocyte and leucocyte adhesion during simulated blood flow.
    White J; Krishnamoorthy S; Gupta D; Lancelot M; Moore N; Sarnaik S; Hobbs WE; Light DR; Hines P
    Br J Haematol; 2016 Sep; 174(6):970-82. PubMed ID: 27291690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivatives.
    Schlesinger M; Schmitz P; Zeisig R; Naggi A; Torri G; Casu B; Bendas G
    Thromb Res; 2012 May; 129(5):603-10. PubMed ID: 22099706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridone derivatives as potent and selective VLA-4 integrin antagonists.
    Witherington J; Bordas V; Gaiba A; Green PM; Naylor A; Parr N; Smith DG; Takle AK; Ward RW
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2256-9. PubMed ID: 16455247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of VLA-4 binding for experimental melanoma metastasis and its inhibition by heparin.
    Schlesinger M; Roblek M; Ortmann K; Naggi A; Torri G; Borsig L; Bendas G
    Thromb Res; 2014 May; 133(5):855-62. PubMed ID: 24636486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly constrained bicyclic VLA-4 antagonists.
    Chang LL; Truong Q; Doss GA; MacCoss M; Lyons K; McCauley E; Mumford R; Forrest G; Vincent S; Schmidt JA; Hagmann WK
    Bioorg Med Chem Lett; 2007 Feb; 17(3):597-601. PubMed ID: 17118652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.